Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | AHR | P35869 | 1/20 | 0.62 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.60 |
| ▸ | HTR2A | P28223 | 4/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.55 |
| ▸ | HTR2C | P28335 | 3/20 | 0.55 |
| ▸ | HTR1D | P28221 | 2/20 | 0.55 |
| ▸ | HTR1B | P28222 | 2/20 | 0.55 |
| ▸ | HTR7 | P34969 | 2/20 | 0.55 |
| ▸ | HTR6 | P50406 | 2/20 | 0.55 |
| ▸ | MPO | P05164 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | CTSK | P43235 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29521038 | 1.00 | MEN1 (0.62) | MEN1CYP3A4KMT2AMAPTAHR | |
| Tetrahydrofuran SCHEMBL28132943 | 0.87 | CSNK2A1 (0.49) | MEN1CYP3A4KMT2AMAPTAHR | |
| Tert-Butyl Formate SCHEMBL28002131 | 0.83 | CTSL (0.47) | MEN1CYP3A4KMT2AMAPTAHR | |
| SCHEMBL31421736 | 0.81 | HTR2A (0.61) | MEN1CYP3A4KMT2AMAPTAHR | |
| SCHEMBL8999077 | 0.81 | HTR2A (0.61) | MEN1CYP3A4KMT2AMAPTAHR | |
| SCHEMBL347688 | 0.81 | MEN1 (0.62) | MEN1CYP3A4KMT2AMAPTAHR | |
| SCHEMBL3225554 | 0.81 | MEN1 (0.62) | MEN1CYP3A4KMT2AMAPTAHR | |
| SCHEMBL1308758 | 0.81 | MEN1 (0.62) | MEN1CYP3A4KMT2AMAPTAHR | |
| SCHEMBL6574193 | 0.79 | CSNK2A1 (0.61) | CSNK2A1MPOSLC6A4 | |
| Indole-3-Carbinol SCHEMBL63995 | 0.78 | MEN1 (0.69) | MEN1CYP3A4KMT2AMAPTAHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1384 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4739326-A2 | PRODUCTION & SECRETION OF AUXIN-LIKE MOLECULES IN BACTERIA | SNIPR Biome ApS (DK) | 2026-05-13 | — | — | EP | claimed |
| CN-120195409-A | Composition for diagnosing sepsis and medicament for sepsis preventive treatment | 北京大学第三医院（北京大学第三临床医学院） | 2025-06-24 | — | — | CN | claimed |
| CN-119924205-A | Rhodiola crenulata tissue culture method | 中国中医科学院中药研究所 | 2025-05-06 | — | — | CN | claimed |
| US-20250084395-A1 | ENGINEERED NITRILASES FOR BIOCATALYSIS | KCAT ENZYMATIC PRIVATE LIMITED (IN) | 2025-03-13 | — | — | US | claimed |
| WO-2025008490-A2 | PRODUCTION & SECRETION OF AUXIN-LIKE MOLECULES IN BACTERIA | SNIPR BIOME APS (DK) | 2025-01-09 | — | — | WO | claimed |
| CN-119265092-A | Production and secretion of indole-3-acetic acid (IAA) in bacteria | 斯尼普生物群系有限公司 | 2025-01-07 | — | — | CN | claimed |
| CN-118844446-A | Application of 3-indoleacetonitrile in pine wood nematode killing effect | 东北林业大学 | 2024-10-29 | — | — | CN | claimed |
| CN-118440868-A | Lactobacillus plantarum and application thereof | 石河子大学 | 2024-08-06 | — | — | CN | claimed |
| CN-115896823-B | D2Method for preparing alpha, beta-deuterated amine medicaments and prodrugs by using O as deuterium source to electrically catalyze nitrile | 天津大学 | 2024-07-26 | — | — | CN | claimed |
| US-20240147927-A1 | METHODS OF HIGH PRODUCTION OF POLYPHENOLS FROM RED LETTUCES AND USES THEREOF | SIGNALCHEM PLANTECH CORPORATION (CA) | 2024-05-09 | — | — | US | claimed |
| US-6264962-B1 | STIMULATION OF SKIN LIPID SYNTHESIS; MOISTURIZATION | SOCIETE L'OREAL S.A. (FR) | 2001-07-24 | — | — | US | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| US-6054137-A | A THERAPEUTIC TREATMENT FOR STIMULATING PROLIFERATION OF HUMAN KERATINOCYTES AND FOR SKIN DISORDERS | SOCIETE L'OREAL S.A. (FR) | 2000-04-25 | — | — | US | claimed |
| EP-0967484-A1 | METHODS FOR DETECTING OR ASSAYING VIRUS | Advanced Life Science Institute, Inc. (JP) | 1999-12-29 | — | — | EP | claimed |
| CN-1239548-A | Method for detecting or determining viruses | TONEN CORP (JP) | 1999-12-22 | — | — | CN | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240147927-A1 | METHODS OF HIGH PRODUCTION OF POLYPHENOLS FROM RED LETTUCES AND USES THEREOF | LCT, ACE2, MYB | MEN1 2686/4885CYP3A4 1668/4885KMT2A 1102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.